Gastroenterology
Volume 120, Issue 6 , Pages 1526-1540 , May 2001

AGA technical review on celiac sprue

References 

  1. Dicke WK, Weijers NA, van der Kamer JH. Coeliac disease. The presence in wheat of a factor having a deliterious effect in cases of coeliac disease. Acta Paediatr. 1953;42:34–42
  2. van de Kamer JH, Weijers HA, Dicke WK. Coeliac disease IV. An investigation into the injurious constituents of wheat in connection with their action on patients with coeliac disease. Acta Paediatr. 1953;42:223–231
  3. Paulley JW, Fairweather FA, Leemin A. Postgastrectomy steatorrhea and patchy jejunal atrophy. Lancet. 1957;1:406–407
  4. Hin H, Bird G, Fisher P, Mahy N, Jewell D. Coeliac disease in primary care: a case finding study. BMJ. 1999;318:164–167
  5. Sheldon W. Prognosis in early adult life of coeliac children treated with a gluten-free diet. BMJ. 1969;2:401–404
  6. Holmes GKT, Stokes PL, Sorahan TM, Prior P, Waterhouse JAH, Cooke WT. Coeliac disease, gluten-free diet and malignancy. Gut. 1976;17:612–619
  7. Collin P, Reunala T, Pukkala E, Laippala P, Keyilainen O, Pasternack A. Coeliac disease: associated disorders and survivial. Gut. 1994;35:1215–1218
  8. Kiln G, Holmes GKT, Cooper BT, Thompson H, Allan RN. Association of coeliac disease and inflammatory bowel disease. Gut. 1980;21:636–641
  9. Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiological approach to the spectrum of gluten sensitivity (“coeliac sprue”). Gastroenterology. 1992;102:330–354
  10. Frazer AC, Fletcher RF, Ross CAS, Shaw B, Sammons HG, Schneider R. Gluten-induced enteropathy. The effect of partially digested gluten. Lancet. 1959;2:252–255
  11. Hekkens WJM, Haex AJ, Willihager RGJ. Some aspects of gliadin fractionation and testing by histochemical methods. In:  Booth CC,  Dowling RH editor. Coeliac disease. Edinburgh: Churchill Livingstone; 1970;p. 11–19
  12. Kagnoff MF, Raleigh KA, Hubert JJ, Bernardin JE, Kasarda DD. Possible role for a human adenovirus in the pathogenesis of coeliac disease. J Exp Med. 1984;160:1544–1557
  13. Kagnoff MF, Paterson NY, Kumar PJ, et al.  Evidence for the role of a human intestinal adenovirus in the pathogenesis of coeliac disease. Gut. 1987;28:995–1001
  14. Kasarda DD, Okita TW, Bernardin JE, Backer PA, Nimmo C, Lew E, et al. Nucleic acid (cDNA) and amino acid sequences of α-type gliadins from wheat (Triticum Aestivum). Proc Natl Acad Sci U S A. 1984;87:4712–4716
  15. de Ritis G, Auricchio S, Jones HW, Lew EJ-L, Bernardin JE, Kasarda DD. In vitro (organ culture) studies of the toxicity of specific A-gliadin peptides in celiac disease. Gastroenterology. 1988;94:41–49
  16. Gjertsen HA, Lundin KEA, Sollid LM, Eriksen JA, Thorsby E. T-cells recognise a peptide derived from α-gliadin presented by the celiac disease associated HLA-DQ (α1*0501, β1*0201) heterodimer. Hum Immunol. 1994;39:243–252
  17. Sturgess RP, Day P, Ellis HJ, Lundin KEA, Gjertsen H, Kontakou M, et al. Wheat peptide challenge in coeliac disease. Lancet. 1994;343:758–761
  18. Molberg O, McAdam SN, Korner R, Quarsten H, Kristiansen C, Madsen L, et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognised by gut-derived T-cells in celiac disease. Nat Med. 1998;4:713–717
  19. Sollid LM, Markussen G, Ek J, Gjerde H, Vartdal F, Thorsby E. Evidence for a primary asociation of coeliac disease to a particular HLA-DQ α/β heterodimer. J Exp Med. 1989;169:345–350
  20. Tighe MR, Hall MA, Ashkenazi A, Siegler E, Lanchbury JSS, Ciclitira PJ. Coeliac disease among Ashkenazi Jews from Israel. A study of the HLA-class II alleles and their associations with disease susceptibility. Hum Immunol. 1993;38:270–276
  21. Marsh MN, Bjarnason I, Shaw J, Ellis A, Baker R, Peters TJ. Studies of intestinal lymphoid tissue. XIV-HLA static mucosal morphology permeability and epithelial lymphocyte population in first degree relatives of patients with coeliac disease. Gut. 1990;31:32–36
  22. Walker-Smith JA. Celiac disease. In:  Walker WA,  Durie PR,  Hamilton JR,  Walker-Smith JA editor. Pediatric intestinal disease. Volume 2:Philadelphia: Decker; 1991;p. 700–718
  23. Greco L, Corazza G, Babron M-C, Clot F, Fulchignono-Lataud M-C, Percopo S, et al. Genome search in celiac disease. Am J Hum Genet. 1998;62:669–675
  24. Zhong F, McCombs CC, Olson JM, Elston RC, Stevens FM, McCarthy CF. An autosomal screen for genes that predispose to celiac disease in the Western counties of Ireland. Nat Genet. 1996;14:329–333
  25. Yiannakou JY, Brett PM, Morris MA, Curtis D, Mathew C, Vaughan R, et al. Family linkage study of the T-cell receptor genes in coeliac disease. Ital J Gastroenterol Hepatol. 1999;31:198–201
  26. Lundin KEA, Scott H, Hansen T, Paulsen G, Halstensen TS, Fausa O, et al. Gliadin specific, HLA-DQ (α1*0501, β1*0201) restricted T-cells isolated from the small intestinal mucosa of coeliac disease patients. J Exp Med. 1993;178:187–196
  27. Nilsen EM, Lundin KEA, Krajci P, Scott H, Sollid LM, Branatzaeg P. Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 and Th0 profile dominated by interferon γ. Gut. 1995;37:766–776
  28. Shidrawi RG, Day P, Przemioslo RT, Ellis HJ, Nelufer JM, Ciclitira PJ. In vitro toxicity of gluten peptides in coeliac disease assessed by organ culture. Scand J Gastroenterol. 1995;30:758–763
  29. Johansen BH, Gjertsen HA, Uartdal F, Buus S, Thorsby E, Lundin KEA, et al. Binding of peptides from N-terminal region of α-gliadin to the celiacassociated HLA-DQ2 DQ2 molecule assessed in biochemical and T cell assays. Clin Immunol Immunopathol. 1996;79:288–293
  30. Shidrawi RG, Parnell NDJ, Ciclitira PJ, Travers P, Evan G, Rosen-Bronson S. Binding of gluten derived peptides to the HLA-DQ2 (α1*0501, β1*0201) molecule, assessed in a cellular assay. Clin Exp Immunol. 1998;111:158–165
  31. Green PA, Wallaeger EE. The clinical behaviour of sprue in The United States. Gastroenterology. 1960;38:399–418
  32. Ferreira M, Lloyd Davies S, Butler M, Scott S, Clark M, Kumar P. Endomysial antibody: is it the best screening test for coeliac disease?. Gut. 1992;33:1633–1637
  33. Lerner A, Kumar V, Iancu TC. Immunological diagnosis of childhood coeliac disease: comparison between antigliadin, antireticulin and antiendomysial antibodies. Clin Exp Immunonol. 1994;95:78–82
  34. Yiannakou JY, Dell'Olio D, Saaka M, Ellis HJ, Rosen-Bronson S, Dumonde DC, et al. Detection and characterisation of antiendomysial antibody in coeliac disease using human umbilical cord. Int Arch Allergy Immunol. 1997;112:140–144
  35. Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med. 1997;3:797–801
  36. Sulkanen S, Halttunen T, Laurila K, Kolho K-L, Korponay-Szabo IR, Sarnesto A, et al. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting coeliac disease. Gastroenterology. 1998;115:1322–1328
  37. Corazza GR, Di Sario A, Cecchetti L, Tarozzi C, et al.  Bone mass and metabolism in patients with celiac disease. Gastroenterology. 1995;109:122–128
  38. McFarlane XA, Bhalla AK, Reeves DE, Morgan LM, Robertson DA. Osteoporosis in treated adult coeliac disease. Gut. 1995;36:710–714
  39. Janatuinen EK, Pikkarainen PH, Kemppanen TD, Kosma VM, Jarvinen RM, Usitupa MI, et al. A comparison of diets with and without oats in adults with celiac disease. N Engl J Med. 1995;333:1033–1037
  40. Walker-Smith JA, Guandalini S, Schmitz J, Schmerling DM, Visakorpi JK. Revised criteria for diagnosis of coeliac disease. Arch Dis Child. 1990;65:909–911
  41. Pink IJ, Creamer B. Response to a gluten-free diet of patients with the coeliac syndrome. Lancet. 1967;1:300–304
  42. Hamilton JR, Chambers RA, Wynn-Williams A. Role of gluten, prednisone and azathioprine in non-responsive coeliac disease. Lancet. 1976;1:1213–1216
  43. Menzies IS. Transmucosal passage of inert molecules in health and disease. In:  Heintze K,  Sradhauge E editor. Intestinal absorption and secretion. Lancaster: MTP Press; 1984;p. 527–548
  44. Bagdi E, Diss TT, Munson P, Isaacson PJ. Mucosal intra-epithelial lymphocytes in enteropathy-associated T-cell lymphoma, ulcerative jejunitis and refractory celiac disease constitute a neoplastic population. Blood. 1999;94:260–264
  45. Loft DE, Marsh MN, Jandle GI, Crowe PT, Garner V, Gordon D, et al. Studies of intestinal lymhphoid tissue XII. Epithelial lymphocyte and mucosal responses to rectal gluten challenge in coeliac sprue. Gastroenterology. 1989;97:29–37
  46. Loft DE, Marsh MN, Crowe PT. Rectal gluten challenge and diagnosis of coeliac disease. Lancet. 1990;335:1293–1295

 Address requests for reprints to: Chair, Clinical Practice and Practice Economics Committee, AGA National Office, c/o Membership Department, 7910 Woodmont Avenue, 7th Floor, Bethesda, Maryland 20814. Fax: (301) 654-5920.

☆☆ This work was supported by the American Gastroenterological Association.

PII: S0016-5085(01)70162-X

Gastroenterology
Volume 120, Issue 6 , Pages 1526-1540 , May 2001